AQR Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $882K | Buy |
108,299
+17,345
| +19% | +$141K | ﹤0.01% | 2286 |
|
|
2025
Q1 | $714K | Buy |
90,954
+65,254
| +254% | +$512K | ﹤0.01% | 2227 |
|
|
2024
Q4 | $383K | Sell |
25,700
-390
| -1% | -$5.81K | ﹤0.01% | 2381 |
|
|
2024
Q3 | $399K | Buy |
26,090
+1,566
| +6% | +$23.9K | ﹤0.01% | 2268 |
|
|
2024
Q2 | $374K | Buy |
24,524
+9,916
| +68% | +$151K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $276K | Buy |
14,608
+3,661
| +33% | +$69.1K | ﹤0.01% | 2157 |
|
|
2023
Q4 | $209K | Buy |
+10,947
| New | +$209K | ﹤0.01% | 2199 |
|
|
2023
Q2 | – | Sell |
-221,257
| Closed | -$4.04M | – | 2264 |
|
|
2023
Q1 | $4.04M | Buy |
221,257
+100,293
| +83% | +$1.83M | 0.01% | 988 |
|
|
2022
Q4 | $2.5M | Buy |
120,964
+856
| +0.7% | +$17.7K | 0.01% | 1165 |
|
|
2022
Q3 | $3.14M | Buy |
120,108
+49,775
| +71% | +$1.3M | 0.01% | 1007 |
|
|
2022
Q2 | $1.78M | Buy |
+70,333
| New | +$1.78M | ﹤0.01% | 1149 |
|
|
2021
Q4 | – | Sell |
-5,869
| Closed | -$205K | – | 2265 |
|
|
2021
Q3 | $205K | Sell |
5,869
-31,770
| -84% | -$1.11M | ﹤0.01% | 2148 |
|
|
2021
Q2 | $1.03M | Sell |
37,639
-9,587
| -20% | -$263K | ﹤0.01% | 1579 |
|
|
2021
Q1 | $1.33M | Sell |
47,226
-18,740
| -28% | -$526K | ﹤0.01% | 1427 |
|
|
2020
Q4 | $1.71M | Buy |
65,966
+526
| +0.8% | +$13.7K | ﹤0.01% | 1242 |
|
|
2020
Q3 | $1.12M | Buy |
65,440
+7,278
| +13% | +$125K | ﹤0.01% | 1360 |
|
|
2020
Q2 | $1.44M | Buy |
58,162
+32,186
| +124% | +$796K | ﹤0.01% | 1304 |
|
|
2020
Q1 | $361K | Sell |
25,976
-971
| -4% | -$13.5K | ﹤0.01% | 1690 |
|
|
2019
Q4 | $272K | Buy |
+26,947
| New | +$272K | ﹤0.01% | 1932 |
|